MOH — authorised 20 November 2008
- Marketing authorisation holder: NOVARTIS PHARMS CORP
- Status: likely_approved
🇮🇱 Promacta in Israel
MOH authorised Promacta on 20 November 2008
Marketing authorisation
Promacta in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Israel
Frequently asked questions
Is Promacta approved in Israel?
Yes. MOH authorised it on 20 November 2008.
Who is the marketing authorisation holder for Promacta in Israel?
NOVARTIS PHARMS CORP holds the Israeli marketing authorisation.